/Investor DB

Canaan Partners — 2015 Investments

25 investments dated 2015 · listed companies and verified rows first · show all

Arvinas Holding Co. LLCarvinas.comin𝕏NASDAQ: ARVNSeries A · Oct 2015 · $15M

Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.

BiotechHealthtechNew Haven, US

Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)inRandy Teel(President and Chief Executive Officer; Director)inCraig Crews(Founder)

BoardStephen Squinto(Director)inLiam Ratcliffe(Director)in

Board seatTimothy Shannon· per SEC Form D

Co-investors5AM VenturesAccess BiotechnologyConnecticut InnovationsElm Street VenturesNextech InvestRA Capital+3 more

NextCurenextcure.comNASDAQ: NXTCSeries A · Dec 2015 · $67M

Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.

BiotechBeltsville, US

Michael Richman(Executive Officer, Director)Timothy Mayer(Executive Officer)inUdayan Guha(Executive Officer)inSteven P. Cobourn(Executive Officer)inSourav Kundu(Executive Officer)inKevin Shaw(Executive Officer)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsBay City CapitalLAVLilly Asia VenturesPfizer Venture InvestmentsQuan CapitalSofinnova Ventures+4 more

Protagonist Therapeuticsprotagonist-inc.comin𝕏NASDAQ: PTGXSeries C · Jul 2015 · $40M

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsAisling CapitalJJDCJohnson & Johnson Innovation – JJDCLilly VenturesRA CapitalStarfish Ventures

Antiva Biosciencesantivabio.cominSeries B · May 2015 · $53M

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

Karl Y. Hostetler(Executive Officer, Director)inGail Maderis(Director)inKristine Ball(President & CEO)inElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRaju Gadiraju(Executive Officer)in

Board seatWende Hutton· per SEC Form D

Co-investorsAdjuvant CapitalAvestria VenturesBrace PharmaGaingelsGV (Google Ventures)HBM Healthcare Investments+6 more

Cargomaticcargomatic.comSeed · Jan 2015 · $3M

Cargomatic operates a marketplace that connects shippers with carriers for local freight, drayage, intermodal, LTL, and full-truckload trucking across the top 20 US ports.

B2B MarketplacesCreator EconomyLogistics & Supply ChainMedia & EntertainmentMobility & TransportationSocialMarina Del Rey, US

Brett Parker(Founder)Jonathan Kessler(Founder)in

Board seatHrach Simonian· per SEC Form D

Co-investorsAcequia Capital (AceCap)Digi VentureseGateway CapitalFJ LabsGreen Meadow VenturesKombo Ventures+16 more

Cidara Therapeuticscidara.comin𝕏Feb 2015SEC filingmedium confidence

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

Jeffrey Stein(Executive Officer, Director)Kevin Judice(Director)inKevin Forrest(Executive Officer)Dirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPaul Daruwala(Executive Officer)in

Board seatNina Kjellson· per SEC Form D · $42M raise · filed Feb 2015

Co-investors5AM VenturesAisling CapitalBain Capital Life SciencesFrazier Life SciencesRA CapitalVivo Capital+1 more

EndoGastric Solutionsendogastricsolutions.com𝕏Apr 2015 · $30M

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.

BiotechHealthtechMedical DevicesSan Mateo, US

Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in

BoardMichael Carusi(Director)inArda Minocherhomjee(Director)

Board seatBrent Ahrens· per SEC Form D

Co-investorsAccelmed PartnersEvidity Health CapitalLightstone VenturesVCFA GroupAdvanced Technology VenturesDe Novo Ventures+2 more

Envisia Therapeuticsenvisiatherapeutics.cominSeries A · Oct 2015 · $25M

Develops novel ocular therapies.

BiotechMorrisville, US

Ben Yerxa(Executive Officer)inEric Linsley(Executive Officer)in

BoardEd Mathers(Director)inSeth Rudnick(Director)inNeal Fowler(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)Pappas Capital+ND CapitalARCH Venture PartnersIllumina VenturesOMX Ventures

Komprisekomprise.comin𝕏Series A · Apr 2015 · $6M

Komprise provides analytics-driven unstructured data management and mobility software that helps enterprises analyze, tier, and move file and object data across storage systems and the cloud, including curating data for AI.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareCampbell, US

Krishna Subramanian(Founder)inKumar Goswami(Executive Officer, Director, Promoter)inMike Peercy(Founder)inKumar K. Goswami(Founder)Michael Peercy(Founder)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsCelesta CapitalMultiplier CapitalWestern Digital CapitalTop Tier Capital PartnersWalden International

Realty Mogulrealtymogul.comin𝕏Jul 2015 · $35MAcquired

RealtyMogul is a real estate crowdfunding platform that enables investors to access commercial real estate investment opportunities.

B2B MarketplacesFintechMarketplacesPropTechLos Angeles, US

Jilliene Helman(Executive Officer, Director, Promoter)inJustin Hughes(Director)in

BoardSteve Ozonian(Director)

Board seatHrach Simonian· per SEC Form D

Co-investorsDraft Ventures LlcGeek VenturesInspire Global VenturesMDT VenturesTechstarsVoiVoda Ventures

RelayRidesinAug 2015

San Francisco, US

Shelby Clark(Director)inAndre Haddad(Executive Officer, Director)Anne Dorman(Executive Officer)in

BoardHoward Hartenbaum(Director)inJoe Kraus(Director)in

Board seatDeepak Kamra· per SEC Form D

Co-investorsAugust CapitalGV (Google Ventures)Shasta VenturesSpero Ventures

Relievant Medsystemsrelievant.comSeries B · Feb 2015 · $5M

Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.

Medical DevicesRedwood City, US

Alex DiNello(Executive Officer, Director)

BoardRichard Mott(Director)Justin Klein(Director)inJason Lettman(Director)John Ryan(Director)

Board seatBrent Ahrens· per SEC Form D

Co-investorsEmergent Medical Partners, LLPLightstone VenturesNew Enterprise Associates (NEA)MorgenthalerVensana Capital

SOASTAsoasta.comSeries A · Aug 2015 · $2M

Mountain View, US

Thomas Lounibos(Executive Officer, Director)Peter Boyes(Executive Officer)Gamiel Gran(Executive Officer)

BoardClint Chao(Director)Blake Modersitzki(Director)in

Board seatJohn Balen· per SEC Form D

Co-investorsMacquarie CapitalPelion Venture Partners

The RealRealtherealreal.comin𝕏Mar 2015 · $20M

The RealReal is an online marketplace for authenticated luxury consignment, allowing consumers to buy and sell pre-owned designer clothing, accessories, jewelry, watches, and home goods.

Circular EconomyConsumerE-commerceMarketplacesSan Francisco, US

Julie Wainwright(Founder)Matt Gustke(Executive Officer)inHenry V. Barry(Executive Officer)

BoardMathias Schilling(Director)inCynthia Ringo(Director)Keval Desai(Director)in

Board seatMaha Ibrahim· per SEC Form D

Co-investorsAcrew CapitalAspect VenturesBright Pixel CapitalDBL PartnersExpansion Venture CapitalGreycroft+13 more

Unchained Labsunchainedlabs.comin𝕏Series A · Feb 2015 · $25M

Unchained Labs builds instruments for lipid nanoparticle and other nanomedicine production, spanning R&D formulation screening through GMP-compliant clinical manufacturing.

AI & Machine LearningBiotechHardwareHealthtechPleasanton, US

Tim Harkness(Executive Officer, Director)inJason Novi(Executive Officer)in

BoardHeather Preston(Director)inJack Nielsen(Director)inJoe Keegan(Director)

Board seatBrent Ahrens· per SEC Form D

Co-investorsCEI VenturesTri-Valley VenturesTPG

Unifi SoftwareinOct 2015

San Mateo, US

Ayush Parashar(Executive Officer)inJames Carr(Executive Officer)Sean Keenan(Executive Officer)inRobert Carlson(Executive Officer, Director)

BoardRoseanne Wincek(Director)Mike Asher(Director)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsBlue Cloud VenturesPelion Venture PartnersRenegade PartnersScale Venture Partners

Virgin Pulsevirginpulse.comAug 2015SEC filingmedium confidence

Denver, US

Board seatNina Kjellson· per SEC Form D · $45M raise · filed Dec 2015

Co-investorsBessemer Venture PartnersExcel Venture ManagementInsight PartnersMarlin Equity PartnersNew Enterprise Associates (NEA)

Imanis Dataimanisdata.comSeries A · Aug 2015 · $12M

Co-investorsWipro Ventures

NatureBoxnaturebox.comMay 2015 · $30M

San Carlos, US

Gautam Gupta(Executive Officer, Director)inKenneth Chen(Executive Officer, Director)Carrie Kalinowski(Executive Officer)

BoardWarren Lee(Director)inNeil Sequeira(Director)Barry McCarthy(Director)

Co-investorsMontage CapitalGeneral CatalystGlobal Founders CapitalRedpoint VenturesSoftBank CapitalSoftBank Group+1 more

Tubular Video analytics platformtubularlabs.comin𝕏Apr 2015Acquired

Tubular provides a video analytics and audience insights platform that helps content strategists identify trending topics, benchmark performance across social platforms, and find gaps in content demand.

Creator EconomyData & InfrastructureMarketing TechMedia & EntertainmentMountain View, US

Rob Gabel(Founder)inAllison Stern(Founder)

BoardMatt Coffin(Director)Rick Heitzmann(Director)inAllen DeBevoise(Director)Warren Lee(Director)in

Co-investorsBling CapitalLerer HippeauMarkerAME Cloud VenturesAmplify.LABessemer Venture Partners+16 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Butterfly HealthLyceraMinimally Invasive DevicesNexcida TherapeuticsTheraclone Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.